OpenAlex
PricingAboutJobs
Log inGet started
Work

The discovery of CCR3/H1 dual antagonists with reduced hERG risk

HTML

Year: 2012
Type: article
Source: Bioorganic & Medicinal Chemistry Letters
DOI: 10.1016/j.bmcl.2012.08.124
Authors: Ash Bahl, Patrick Barton, Keith Bowers, Steven Brough, Richard Evans, Christopher A. Luckhurst, Tobias Mochel, Matthew W.D. Perry, Aaron Rigby, Robert J. Riley, Hitesh Sanganee, Adam Sisson, Brian Springthorpe
Institution: AstraZeneca (United Kingdom)
Language: English

Topic: Chemokine receptors and signaling
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: CCR3 antagonists, histamine H1 receptor antagonists, dual receptor antagonists, hERG liability, cardiac safety, physicochemical properties, physical form, drug discovery
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2079110646
FWCI: 0.764
Cites: 35
Cited by: 23
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security